


Harold D.
Efficient and easy
In stock · arrives 2 to 4 working days after payment
Pay by card or PayPal (confirmed instantly), Instant EFT, EFT or crypto
Damaged or wrong? We replace or refund
Packed and shipped from Cape Town, South Africa. Dispatched within 24 to 36 hours, then tracked courier (Aramex or The Courier Guy) to your door in 1 to 3 working days.
SS-31 (Elamipretide) is a mitochondria-targeted antioxidant peptide that localises to the inner mitochondrial membrane and reduces reactive oxygen species — making it central to research into ageing, heart failure and metabolic disease.
Where we hold an independent Janoshik report for a compound we publish it in full - batch number, purity and a verification key you can check against the lab yourself. Where we do not hold one the product is marked research grade and we say so, rather than claim a report we cannot produce.
The short version: SS-31 is elamipretide, a four-amino-acid peptide that targets the inner membrane of mitochondria. In September 2025 the US FDA granted it accelerated approval, as Forzinity, for the rare inherited disease Barth syndrome.
Elamipretide has gone by several names: SS-31, MTP-131 and Bendavia. It is a tetrapeptide that gets into many cell types and gathers in mitochondria, the parts of the cell that produce most of its energy. There it binds cardiolipin, a fat in the inner mitochondrial membrane. That is thought to steady the folded inner membranes, called cristae, cut oxidative stress and support energy production.
On 19 September 2025 the FDA granted accelerated approval to Forzinity (elamipretide) as the first treatment for Barth syndrome. The disease mainly affects males, often begins with severe heart failure in infancy, and leaves survivors with fatigue and poor exercise tolerance. The approval rested on stronger knee extensor muscles, a measure the FDA judged reasonably likely to predict real benefit, such as standing up more easily. A confirmatory placebo-controlled trial is a condition of keeping it.
Elsewhere the record is mixed. MMPOWER-3, a phase 3 trial in 218 adults with primary mitochondrial myopathy (Neurology, 2023), missed both main goals: six-minute walking distance and fatigue scores did not improve against placebo, although the drug was well tolerated.
The approval is narrow: one very rare disease, a stand-in measure, and proof of real benefit still owed. In the larger myopathy trial it failed its primary endpoints. The positive data all come from the licensed medicine given under medical supervision. A vial of research-grade SS-31 has been through none of that review, so these results don't describe it.
It arrives as a freeze-dried powder. Once bacteriostatic water goes in, it belongs in the fridge. Our reconstitution and storage guide covers the details, and the calculator does the maths.
Now an approved medicine for one rare disease, after a phase 3 miss in a broader one.
For research use only. Not for human consumption. Nothing on this page is medical advice.
No reviews from orders with SS-31 yet. Here is what recent customers said about ordering from us.
★★★★★
Efficient and easy
Harold D. · 18 Nov 2026
★★★★★
I went on holiday and stressed that I would not get my research materials in time, but you and the delivery company did not disappoint! Thank you for excellent pre order advice on products, user friendly ordering system, and superb delivery system!!!
Nicoleen · 18 Nov 2026
★★★★★
You guys are the best. Prices are good and service is outstanding
Glenda S. · 17 Nov 2026
★ 4.9 across all 117 AP reviews, good and bad. See them. Every reviewer gets R100 store credit, whatever they rate.
Follow my channel — every couple of weeks I drop one genuinely useful thing: how to read a COA, reconstitution math, the odd honest deal. No spam, no hype.
Follow Lab Notes on WhatsAppFree · follow & mute anytime · research use only. New here? WELCOME99 = R99 off a first order of R400 or more (doesn’t stack with sale discounts) →
Please read before entering this website.
All products offered on this website are strictly intended for scientific research and laboratory use only. They are not intended for human consumption, veterinary use, or any other purpose outside of controlled research environments.
These products have not been evaluated, approved, or certified by the South African Health Products Regulatory Authority (SAHPRA), the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), or any other regulatory authority for use in humans or animals.
By entering this website you confirm that:
AP accepts no liability for misuse of any product sold on this platform.
Join our email list and we’ll put WELCOME99 on your basket now: R99 off a first order of R400 or more. You’ll get restock news and the odd offer. Unsubscribe any time.
One use per email, first order only. Doesn’t stack with sale discounts. Research use only.
It’s on your basket: R99 off your first order of R400 or more.
Go to checkoutWe only deliver in South Africa for now. Tell us where you are, and we’ll let you know if we start delivering there.
We only use this to tell you about delivery to your country.
We’re counting where people want delivery. The countries with the most interest come first.
Chats are read by the AP team to help you. Never share card details here. Prefer a person? WhatsApp us